Weiss Asset Management LP Oncocyte Corp Transaction History

Weiss Asset Management LP

  • $1.69 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$1.51 - $2.27 $27,631 - $41,538
-18,299 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$1.59 - $2.51 $636 - $1,003
-400 Reduced 2.14%
18,299 $38,000
Q2 2019

Aug 14, 2019
BUY
$2.49 - $5.45 $46,560 - $101,909
18,699 New
18,699 $47,000

Others Institutions Holding OCX

# of Institutions
4
Shares Held
1.51M
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $344M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Weiss Asset Management LP Portfolio

Follow Weiss Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email